Soliton, Inc. SOLY

Full chart Compare
Set alert

Price alert · SOLY

All alert types
22.58 0.00 (+0.00%)

Apr 24, 2025, 3:47 PM EDT

22.56 Day range 22.59

52-week range unavailable

Revenue (ttm)
370.00K
Shares out
21.60M
Forward P/E
-26.26
Volume
1.35M
Open
22.56
Previous close
22.58
Day's range
22.56 – 22.59
Beta
0.18
Analysts
Hold
Earnings date
Dec 23, 2021

2Y +2.06 (+10.04%)

202122Nov 21Dec 2122.58

Key statistics

Enterprise value
465.90M
PEG ratio
-0.51
Price / sales
1317.97
Price / book
22.83
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-10.11M
Total cash
21.75M
Total debt
0
Return on equity
-63.97%
Short % of float
14.11%
50-day average
20.88
200-day average
20.64

Financials — quick view

All financials
SOLY Revenue — quarterly 370.00K
2017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 2021
SOLY Net income — quarterly -272.00K
2017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 2021
SOLY EPS — quarterly -0.01
2017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 2021

Earnings

SOLY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 23, 2021Sep 1, 2021-0.32———
Aug 12, 2021Jun 1, 2021-0.31———
May 12, 2021Mar 1, 2021-0.24———
Mar 4, 2021Dec 1, 2020-0.22———
Nov 12, 2020Sep 1, 2020-0.16———
Aug 11, 2020Jun 1, 2020-0.19———

Upgrades / downgrades

SOLY analyst upgrades and downgrades
DateFirmActionFromTo
Jun 2, 2021Roth CapitaldownBuyNeutral
May 13, 2021Cantor FitzgeralddownOverweightNeutral
Jul 15, 2020Cantor Fitzgeraldinit—Overweight

About Soliton, Inc.

Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
soliton.com

News

Your note

Sign in to keep a note on SOLY — it syncs with the Stock Master app.

Insider holders

SOLY insider holders
InsiderRelationLatest transactionDateShares held
REMEDITEX VENTURES, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityPurchaseJun 29, 20200

Institution ownership

SOLY institution ownership
Holder% heldSharesValueReported
Sio Capital Management, LLC3.82%824,80316.79MSep 29, 2021
Blackrock Inc.3.39%731,48414.89MSep 29, 2021
Vanguard Group, Inc. (The)2.87%619,75712.62MSep 29, 2021
Polar Asset Management Partners Inc.2.63%568,30911.57MSep 29, 2021
Millennium Management LLC2.29%493,59610.05MSep 29, 2021
First Trust Capital Management L.P.1.73%373,0047.59MSep 29, 2021

Fund ownership

SOLY fund ownership
Holder% heldSharesValueReported
First Tr Exchange Traded Fd-First Trust Merger Arbitrage Fd1.71%369,4607.52MSep 29, 2021
Vanguard Total Stock Market Index Fund1.41%304,1696.19MSep 29, 2021
iShares Russell 2000 ETF1.25%270,5145.57MOct 30, 2021
Vanguard Extended Market Index Fund0.67%145,6362.97MSep 29, 2021
iShares Russell 2000 Growth ETF0.42%90,3371.86MOct 30, 2021
IndexIQ Tr-IQ Merger Arbitrage ETF0.38%81,8571.67MSep 29, 2021